---
title: "DAXXIFY®"
---

## What is DAXXIFY®?

DAXXIFY® is a neuromodulator for frown lines, the vertical lines between your brows [1]. Like other neuromodulators, it relaxes the muscles behind those lines, so the skin above them smooths out and you look rested and refreshed.

What sets DAXXIFY® apart is how long it lasts. In its two main studies, frown lines stayed smooth or nearly smooth for a median of about 24 weeks, close to six months [2].

## Why choose DAXXIFY® at MD TLC™?

At MD TLC™, [Dr. Quibell](/providers/dianne-quibell-md/) performs every injection herself. She is an internationally renowned physician and educator who has trained several thousand clinicians in laser and light-based technology, injectables and other regenerative therapies.

She offers every leading neuromodulator, including [BOTOX® Cosmetic](/treatments/botox-cosmetic/), [Dysport®](/treatments/dysport/), [Xeomin®](/treatments/xeomin/), [Jeuveau®](/treatments/jeuveau/) and [Letybo®](/treatments/letybo/), and chooses the one that suits your face and your goals.

## Made differently

According to its maker, DAXXIFY® is the first neuromodulator whose active ingredient is kept stable without human blood products or animal byproducts [3]. A peptide does that job instead [4].

## What to expect

### Before

Your visit starts with a consultation with Dr. Quibell, who looks at how your face moves and plans where each injection goes.

### During

A few quick injections between the brows. A session is a short office visit, and you can go back to your day.

### After

Results can show as early as the next day, and typically within two days [5]. In its main studies they lasted a median of about 24 weeks [2].

## Questions

**Q: How long does DAXXIFY® last?**

In its two main studies, frown lines stayed smooth or nearly smooth for a median of about 24 weeks, close to six months.

**Q: How soon will I see results?**

As early as the next day, and typically within two days.

**Q: How is DAXXIFY® different from other neuromodulators?**

Every neuromodulator relaxes the muscles behind expression lines. DAXXIFY® is kept stable with a peptide instead of human blood products or animal byproducts, and its results lasted a median of about 24 weeks in its main studies. Dr. Quibell will help you choose the one that suits you.

**Q: Can DAXXIFY® treat other lines?**

DAXXIFY® is approved for frown lines. Dr. Quibell will talk with you about the lines you want to soften and the best way to treat each one.

Wellesley, Massachusetts

## Schedule DAXXIFY® in Wellesley, MA

If you’re interested in what DAXXIFY® can do for you, call [(781) 431-0002](tel:7814310002) or schedule your consultation online. We look forward to seeing you!

## References

> DAXXIFY is indicated for the treatment of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
— [U.S. Food and Drug Administration. DAXXIFY (daxibotulinumtoxinA-lanm) approval letter, BLA 761127. September 7, 2022.](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761127Orig1s000ltr.pdf)

> In two phase 3 trials (SAKURA 1 and 2), glabellar lines rated none or mild were maintained for a median of 24.0 and 23.9 weeks, and lines took a median of 27.7 and 26.0 weeks to return to baseline.
— [Carruthers JD, et al. DaxibotulinumtoxinA for injection for the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Plast Reconstr Surg. 2020. PMID 31609882.](https://pubmed.ncbi.nlm.nih.gov/31609882/)

> DAXXIFY is the first formulation to stabilize the active ingredient without the use of human blood products or animal byproducts.
— [Revance. The DAXXIFY difference.](https://www.daxxify.com/the-daxxify-difference)

> DAXXIFY is formulated with a 35 amino acid peptide excipient (RTP004) that prevents surface adsorption and promotes thermal stability.
— [DailyMed. DAXXIFY (daxibotulinumtoxinA-lanm) injection: prescribing information.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74)

> Results are seen as early as the next day and typically within 2 days (from patient diaries in the clinical trials).
— [Revance. DAXXIFY.](https://www.daxxify.com/)


```ld+json
{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@context": "https://schema.org",
            "@type": "Service",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#service",
            "name": "DAXXIFY®",
            "url": "https://www.mdtlc.com/treatments/daxxify/",
            "description": "DAXXIFY® is a long-lasting neuromodulator for frown lines, kept stable with a peptide instead of human blood products.",
            "provider": {
                "@type": "Organization",
                "name": "MD TLC"
            }
        },
        {
            "@context": "https://schema.org",
            "@type": "MedicalWebPage",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#webpage",
            "name": "DAXXIFY®",
            "url": "https://www.mdtlc.com/treatments/daxxify/",
            "mainEntity": {
                "@id": "https://www.mdtlc.com/treatments/daxxify/#service"
            },
            "speakable": {
                "@type": "SpeakableSpecification",
                "cssSelector": [
                    ".geo-summary"
                ]
            },
            "citation": [
                {
                    "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-876dcfb3"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-cb8a774d"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-1af5e91e"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-c83b70ef"
                },
                {
                    "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-68400b31"
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "BreadcrumbList",
            "itemListElement": [
                {
                    "@type": "ListItem",
                    "position": 1,
                    "name": "Home",
                    "item": {
                        "@id": "https://www.mdtlc.com/",
                        "@type": "WebSite",
                        "name": "Home"
                    }
                },
                {
                    "@type": "ListItem",
                    "position": 2,
                    "name": "Treatments",
                    "item": {
                        "@id": "https://www.mdtlc.com/treatments/",
                        "@type": "CollectionPage",
                        "name": "Treatments"
                    }
                },
                {
                    "@type": "ListItem",
                    "position": 3,
                    "name": "DAXXIFY®",
                    "item": "https://www.mdtlc.com/treatments/daxxify/"
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "Question",
            "name": "DAXXIFY®",
            "acceptedAnswer": {
                "@type": "Answer",
                "text": "DAXXIFY® is a long-lasting neuromodulator that smooths the frown lines between your brows. It is kept stable with a peptide instead of human blood products, results can show as early as the next day, and in its main studies lines stayed smooth for a median of about 24 weeks. Dr. Quibell offers it at MD TLC™ in Wellesley, MA."
            },
            "isPartOf": {
                "@id": "https://www.mdtlc.com/treatments/daxxify/#webpage"
            },
            "url": "https://www.mdtlc.com/treatments/daxxify/"
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "How long does DAXXIFY® last?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>In its two main studies, frown lines stayed smooth or nearly smooth for a median of about 24 weeks, close to six months.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "How soon will I see results?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>As early as the next day, and typically within two days.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "How is DAXXIFY® different from other neuromodulators?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>Every neuromodulator relaxes the muscles behind expression lines. DAXXIFY® is kept stable with a peptide instead of human blood products or animal byproducts, and its results lasted a median of about 24 weeks in its main studies. Dr. Quibell will help you choose the one that suits you.</p>"
                    }
                },
                {
                    "@type": "Question",
                    "name": "Can DAXXIFY® treat other lines?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "<p>DAXXIFY® is approved for frown lines. Dr. Quibell will talk with you about the lines you want to soften and the best way to treat each one.</p>"
                    }
                }
            ]
        },
        {
            "@context": "https://schema.org",
            "@type": "CreativeWork",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-876dcfb3",
            "name": "U.S. Food and Drug Administration. DAXXIFY (daxibotulinumtoxinA-lanm) approval letter, BLA 761127. September 7, 2022.",
            "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761127Orig1s000ltr.pdf"
        },
        {
            "@context": "https://schema.org",
            "@type": "ScholarlyArticle",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-cb8a774d",
            "name": "Carruthers JD, et al. DaxibotulinumtoxinA for injection for the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Plast Reconstr Surg. 2020. PMID 31609882.",
            "url": "https://pubmed.ncbi.nlm.nih.gov/31609882/"
        },
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-1af5e91e",
            "name": "Revance. The DAXXIFY difference.",
            "url": "https://www.daxxify.com/the-daxxify-difference"
        },
        {
            "@context": "https://schema.org",
            "@type": "CreativeWork",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-c83b70ef",
            "name": "DailyMed. DAXXIFY (daxibotulinumtoxinA-lanm) injection: prescribing information.",
            "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74"
        },
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "@id": "https://www.mdtlc.com/treatments/daxxify/#citation-68400b31",
            "name": "Revance. DAXXIFY.",
            "url": "https://www.daxxify.com/"
        }
    ]
}
```
